Αρχική World News Study Finds Accelerated Partial-Breast Radiation Just as Effective as Whole Breast Radiation

Study Finds Accelerated Partial-Breast Radiation Just as Effective as Whole Breast Radiation

Many breast cancer patients use radiation treatment to help kill any remaining cancer cells and keep them from returning. But a traditional whole-breast radiation treatment takes at least three or four weeks and often as much as six weeks. It can also cause some painful side effects, such as fatigue, rash, dry or peeling skin, nerve damage, or swollen lymph nodes.Now, however, the results of a long-term study comparing whole-breast radiation and accelerated partial-breast radiation (APBI) have revealed that the latter option is not only faster and less invasive, but it may be just as effective as whole-breast radiation.The study investigated 10-year recurrence rates for 520 breast cancer patients who underwent either whole-breast or accelerated partial-breast radiation therapy as part of their treatment. The participants were all women over 40, and most were over 50. All had stage I or II breast cancer, most often hormone-receptor-positive and HER-2 negative.Photo: Adobe Stock/Photographee.eu
Those who did the partial-breast radiation, which only takes 10 days instead of several weeks, were not found to have a higher rate of cancer recurrence five years after their treatment. After ten years, their recurrence rate was 3.3 percent, compared to 2.6 percent of whole-breast radiation patients, a difference that researchers say is not statistically significant.Survival rates between the two methods of radiation were also similar, at 97.6 percent for partial-breast radiation and 97.5 percent for whole-breast radiation.“APBI is a safe and less invasive treatment as compared to whole breast irradiation,” said the study’s lead author, Dr. Icro Meattini, an associate professor at the University of Florence in Italy. “It is cost-effective and the overall treatment time is diminished.”
Photo: Adobe Stock/Mark KostichPartial-breast radiation focuses on just the area of the breast where the cancer was found, diminishing the side effects of the treatment. Receiving a higher dose for a shorter amount of time can also reduce side effects (as doctors and patients both agreed) and help patients cope with treatment. While it is important to analyze the treatment options on a case-by-case basis, Meattini believes partial-breast radiation should be an option offered to many breast cancer patients.This is great news for the cancer field, as it may mean an extra option for women with early-stage breast cancer. The concept may also be applicable to radiation treatment for other types of cancers in the future.“This study showed that the 10-year rates of recurrence were similar to the five-year rates, and adds to the growing body of research that suggests more is not always better,” says Dr. Stephanie Bernik, chief of breast service at Mount Sinai West in New York City, who was not involved in the study.
Photo: Adobe Stock/Evgeniy KalinovskiyBernik also says that having partial-breast radiation as a standard treatment option will allow women to get back to work faster and will allow women who do not have easy access to a radiation center to choose radiation treatment too. “Many women do not live close to a treatment center, but might now consider spending a week away from home compared to over a month,” she says.Which type of radiation would you prefer and why? Larger studies on this topic are needed to demonstrate APBI’s effectiveness, but faster treatment and fewer side effects are certainly things to get excited about!
Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

FDA Approves Companion Diagnostic to Identify NTRK Fusions in Solid Tumours for Larotrectinib

On 23 October 2020, the US Food and Drug Administration (FDA) approved the next-generation sequencing (NGS)-based FoundationOne CDx test (Foundation Medicine, Inc.) as a...

An existing blood test for ovarian cancer has been re-evaluated. The results are in.

Ovarian cancer is the sixth most common cancer in women in the UK, with about 7,400 new cases every year. This number equates to...

Teacher Is Glad She Asked for More Testing After Mammogram Failed to Detect Her Breast Cancer

Martha Gray has a long history of breast cancer in her family, so she knows that she needs to take her mammograms seriously every...

How to Stay Healthy After Cancer

I try to pack helpful advice into every follow-up visit I have with patients, focusing on little tips that help foster healthy lifestyles. This...

Feasibility and Preliminary Efficacy Results of the Beat AML Study

Precision medicine in acute myeloid leukaemia (AML) is feasible in terms of providing cytogenetic and mutational data within 7 days, allowing their rapid incorporation into...

Woman Battles Breast Cancer While Pregnant, Delivers Healthy Baby Boy

When she was six months pregnant, Desiree Doughty noticed that something seemed to be wrong with her breasts. “I noticed that one of my breasts...